Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Review Article

Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril?

Author(s): Ozgur Karcioglu*, Canan Akman and Ilknur Atnis

Volume 30, Issue 8, 2024

Published on: 21 February, 2024

Page: [578 - 588] Pages: 11

DOI: 10.2174/0113816128284720240212111926

Price: $65

Abstract

Clostridium botulinum toxin-A (BoNT-A) creates temporary paralysis in the muscles by acting on the muscle-nerve junction. It is injected into the mimic muscles when a decrease in the movements of the mimic muscles is desired. Despite many favorable applications, the use of BoNT-A is not without drawbacks. Although there is no expected serious side effect on health in BoNT-A treatments, various problems can be encountered in patients treated for aesthetic purposes. Botulism is a rare but potentially life-threatening syndrome, which is caused by the toxin produced by the bacterium Clostridium botulinum, which acts on the nervous system, vegetative forms of C. botulinum can only survive in anaerobic conditions, while spore forms are common in nature and can withstand harsh conditions. Botulism can stem from bacterial spores which release toxin in the body; in the form of enteric botulism, and wound botulism. The cases that develop ‘iatrogenic botulism’ after such procedures are usually those receiving high-dose toxin for therapeutic purposes. The treatment of botulism mainly consists of anti-toxin therapy and, if necessary, intensive care to prevent organ failures, including respiratory support. This article aims to cover all these issues related to botulism and other adverse outcomes related to BoNT-A injection in light of the most recent literature.

[1]
Jewell ML, Monheit GD. An overview of clinical trial data on a new formulation of botulinum neurotoxin type A. Aesthet Surg J 2009; 29(S6): S31-3.
[http://dx.doi.org/10.1016/j.asj.2009.09.011] [PMID: 19945002]
[2]
Berry MG, Stanek JJ. Botulinum neurotoxin A: A review. J Plast Reconstr Aesthet Surg 2012; 65(10): 1283-91.
[http://dx.doi.org/10.1016/j.bjps.2012.04.016] [PMID: 22552262]
[3]
Pasricha TS, Pasricha PJ. Botulinum toxin injection for treatment of gastroparesis. Gastrointest Endosc Clin N Am 2019; 29(1): 97-106.
[http://dx.doi.org/10.1016/j.giec.2018.08.007] [PMID: 30396531]
[4]
Erbguth FJ. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord 2004; 19(S8): S2-6.
[http://dx.doi.org/10.1002/mds.20003] [PMID: 15027048]
[5]
Carr WW, Jain N, Sublett JW. Immunogenicity of botulinum toxin formulations: Potential therapeutic implications. Adv Ther 2021; 38(10): 5046-64.
[http://dx.doi.org/10.1007/s12325-021-01882-9] [PMID: 34515975]
[6]
Lewandowski M, Świerczewska Z, Barańska-Rybak W. Off-label use of botulinum toxin in dermatology-current state of the art. Molecules 2022; 27(10): 3143.
[http://dx.doi.org/10.3390/molecules27103143] [PMID: 35630620]
[7]
Phan K, Younessi S, Dubin D, Lin MJ, Khorasani H. Emerging OFF-LABEL esthetic uses of botulinum toxin in dermatology. Dermatol Ther 2022; 35(1): e15205.
[http://dx.doi.org/10.1111/dth.15205] [PMID: 34792262]
[8]
Hafeez MU, Moore M, Hafeez K, Jankovic J. Exploring the role of botulinum toxin in critical care. Expert Rev Neurother 2021; 21(8): 881-94.
[http://dx.doi.org/10.1080/14737175.2021.1958678] [PMID: 34281468]
[9]
American Society for Aesthetic Plastic Surgery Website. Cosmetic Surgery National Data Bank Statistics. 2008. Available from: http://www.surgery.org/sites/default/files/2008stats.pdf
[10]
Nestor MS, Fischer D, Arnold D. “Masking” our emotions: Botulinum toxin, facial expression, and well-being in the age of COVID-19. J Cosmet Dermatol 2020; 19(9): 2154-60.
[http://dx.doi.org/10.1111/jocd.13569] [PMID: 32592268]
[11]
Wortzman MS, Pickett A. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use. Aesthet Surg J 2009; 29(S6): S34-42.
[http://dx.doi.org/10.1016/j.asj.2009.09.014] [PMID: 19945003]
[12]
Pickett A. Dysport®: Pharmacological properties and factors that influence toxin action. Toxicon 2009; 54(5): 683-9.
[http://dx.doi.org/10.1016/j.toxicon.2009.03.020] [PMID: 19332087]
[13]
Hexsel C, Hexsel D, Porto MD, Schilling J, Siega C. Botulinum toxin type A for aging face and aesthetic uses. Dermatol Ther 2011; 24(1): 54-61.
[http://dx.doi.org/10.1111/j.1529-8019.2010.01378.x] [PMID: 21276158]
[14]
Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum a toxin injections. Mov Disord 1994; 9(1): 31-9.
[http://dx.doi.org/10.1002/mds.870090106] [PMID: 8139603]
[15]
Koriazova LK, Montal M. Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat Struct Biol 2003; 10: 13e8.
[http://dx.doi.org/10.1038/nsb879]
[16]
del Boz J, Padilla-España L, Segura-Palacios JM. Botulinum toxin injection technique for axillary hyperhidrosis. Actas Dermosifiliogr 2014; 105(5): 517-8.
[http://dx.doi.org/10.1016/j.adengl.2014.04.011] [PMID: 24468624]
[17]
Iannitti T, Di Cerbo A, Aspiro A, Palmieri B. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis. Drug Des Devel Ther 2014; 8: 931-5.
[http://dx.doi.org/10.2147/DDDT.S60389] [PMID: 25075176]
[18]
Martina E, Diotallevi F, Radi G, Campanati A, Offidani A. Therapeutic use of botulinum neurotoxins in dermatology: Systematic review. Toxins 2021; 13(2): 120.
[http://dx.doi.org/10.3390/toxins13020120] [PMID: 33562846]
[19]
Lu B. The destructive effect of botulinum neurotoxins on the SNARE protein: SNAP-25 and synaptic membrane fusion. PeerJ 2015; 3: e1065.
[http://dx.doi.org/10.7717/peerj.1065] [PMID: 26157630]
[20]
Fujimoto T. Pathophysiology and treatment of hyperhidrosis. Curr Probl Dermatol 2016; 51: 86-93.
[http://dx.doi.org/10.1159/000446786] [PMID: 27584967]
[21]
BOTOX® (onabotulinumtoxinA) for injection, for intramuscular,intradetrusor, or intradermal use. 2022. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103000s5320lbl.pdf
[22]
Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM. A double-blind, randomized, comparative study of DysportR vs. BotoxR in primary palmar hyperhidrosis. Br J Dermatol 2003; 149(5): 1041-5.
[http://dx.doi.org/10.1111/j.1365-2133.2003.05620.x] [PMID: 14632812]
[23]
Pérez-Bernal AM, Avalos-Peralta P, Moreno-Ramírez D, Camacho F. Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experience. J Cosmet Dermatol 2005; 4(3): 163-6.
[http://dx.doi.org/10.1111/j.1473-2165.2005.00304.x] [PMID: 17129260]
[24]
Kim WO, Kil HK, Yoon KB, Noh KU. Botulinum toxin. Dermatol Surg 2009; 35(5): 833-8.
[http://dx.doi.org/10.1111/j.1524-4725.2009.01140.x] [PMID: 19389096]
[25]
Haider A, Solish N. Focal hyperhidrosis: Diagnosis and management. CMAJ 2005; 172(1): 69-75.
[http://dx.doi.org/10.1503/cmaj.1040708] [PMID: 15632408]
[26]
Komericki P, Ardjomand N. Hyperhidrosis of face and scalp: Repeated successful treatment with botulinum toxin type A. Indian J Dermatol Venereol Leprol 2012; 78(2): 201-2.
[http://dx.doi.org/10.4103/0378-6323.93647] [PMID: 22421660]
[27]
BOTOX (onabotulinumtoxinA). Irvine, California: Allergan, Inc 2021.
[28]
Bjerkhoel A, Trobbe O. Frey’s syndrome: Treatment with botulinum toxin. J Laryngol Otol 1997; 111(9): 839-44.
[http://dx.doi.org/10.1017/S0022215100138769] [PMID: 9373550]
[29]
Fedorowicz Z, van Zuuren EJ, Schoones J. Botulinum toxin for masseter hypertrophy. Cochrane Database Syst Rev 2013; 2013(9): CD007510.
[PMID: 24018587]
[30]
Lowe N, Naumann M, Eadie N. Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine 2023; 102(S1): e32764.
[http://dx.doi.org/10.1097/MD.0000000000032764] [PMID: 37499084]
[31]
Nattkemper LA, Vander Does A, Stull CM, et al. Prolonged antipruritic effect of botulinum toxin type A on cowhage-induced itch: A randomized, single-blind, placebo-controlled trial. Acta Derm Venereol 2023; 103: adv6581.
[http://dx.doi.org/10.2340/actadv.v103.6581] [PMID: 37584094]
[32]
Huang SH, Wu KW, Lo JJ, Wu SH. Synergic effect of botulinum toxin type A and triamcinolone alleviates scar pruritus by modulating epidermal hyperinnervation: A preliminary report. Aesthet Surg J 2021; 41(11): NP1721-31.
[http://dx.doi.org/10.1093/asj/sjab105] [PMID: 33662123]
[33]
Cakir C, Oguz Idiz U, Aydin I, Firat D, İbrahim Ulusoy A, Yazici P. Comparison of the effectiveness of two treatment modalities for chronic anal fissure: Botox versus sphincterotomy. Turk J Surg 2020; 36(3): 264-70.
[http://dx.doi.org/10.47717/turkjsurg.2020.4492] [PMID: 33778381]
[34]
Li TT, Liu ZY, Xiong L, Zhang ZW. Clinical efficacy of botulinum toxin type A in the treatment of fasciitis pain: A systematic review and meta-analysis. Medicine 2023; 102(30): e34461.
[http://dx.doi.org/10.1097/MD.0000000000034461] [PMID: 37505140]
[35]
Esquenazi A, Jost WH, Turkel CC, Wein T, Dimitrova R. Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine 2023; 102(S1): e32376.
[http://dx.doi.org/10.1097/MD.0000000000032376] [PMID: 37499086]
[36]
Jankovic J, Tsui J, Brin MF. Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine 2023; 102(S1): e32403.
[http://dx.doi.org/10.1097/MD.0000000000032403] [PMID: 37499081]
[37]
Turkel CC, Aurora S, Diener HC, et al. Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine 2023; 102(S1): e32600.
[http://dx.doi.org/10.1097/MD.0000000000032600] [PMID: 37499085]
[38]
Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J. OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 2015; 156(5): 820-4.
[http://dx.doi.org/10.1097/j.pain.0000000000000119] [PMID: 25735000]
[39]
Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology 2016; 86(19): 1818-26.
[http://dx.doi.org/10.1212/WNL.0000000000002560] [PMID: 27164716]
[40]
Aurora SK, Dodick DW, Turkel CC, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 2010; 30(7): 793-803.
[http://dx.doi.org/10.1177/0333102410364676] [PMID: 20647170]
[41]
Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 2010; 30(7): 804-14.
[http://dx.doi.org/10.1177/0333102410364677] [PMID: 20647171]
[42]
Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 2000; 38(2): 245-58.
[http://dx.doi.org/10.1016/S0041-0101(99)00153-1] [PMID: 10665805]
[43]
Herd CP, Tomlinson CL, Rick C, et al. Botulinum toxins for the prevention of migraine in adults. Cochrane Libr 2018; 2018(6): CD011616.
[http://dx.doi.org/10.1002/14651858.CD011616.pub2] [PMID: 29939406]
[44]
Nitti V, Haag-Molkenteller C, Kennelly M, Chancellor M, Jenkins B, Schurch B. Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine (Baltimore) 2023; 102(S1): e32377.
[http://dx.doi.org/10.1097/MD.0000000000032377] [PMID: 37499088]
[45]
Przydacz M, Golabek T, Chłosta P. How to assess and predict success or failure of intra-detrusor injections with onabotulinumtoxinA. Adv Clin Exp Med 2019; 28(4): 555-67.
[http://dx.doi.org/10.17219/acem/90764] [PMID: 30729759]
[46]
Jankovic J, Carruthers J, Naumann M, et al. Neutralizing antibody formation with OnabotulinumtoxinA (BOTOX®) treatment from global registration studies across multiple indications: A meta-analysis. Toxins 2023; 15(5): 342.
[http://dx.doi.org/10.3390/toxins15050342] [PMID: 37235376]
[47]
Ho WWS, Albrecht P, Calderon PE, et al. Emerging trends in botulinum neurotoxin a resistance: An international multidisciplinary review and consensus. Plast Reconstr Surg Glob Open 2022; 10(6): e4407.
[http://dx.doi.org/10.1097/GOX.0000000000004407] [PMID: 35747253]
[48]
Münchau A, Bhatia KP. Regular review: Uses of botulinum toxin injection in medicine today. BMJ 2000; 320(7228): 161-5.
[http://dx.doi.org/10.1136/bmj.320.7228.161] [PMID: 10634738]
[49]
Allergan Pharmaceuticals Ireland a subsidiary of: Allergan, Inc Prescribing Information for BOTOX. Allergan USA, Inc: Madison, NJ 07940 ©2022 Allergan 2022.
[50]
Naik PP. Utilities of botulinum toxins in dermatology and cosmetology. Clin Cosmet Investig Dermatol 2021; 14: 1319-30.
[http://dx.doi.org/10.2147/CCID.S332247] [PMID: 34584436]
[51]
Li X, Sui C, Xia X, Chen X. Efficacy and safety of botulinum toxin type A for treatment of glabellar lines: A network meta-analysis of randomized controlled trials. Aesthetic Plast Surg 2023; 47(1): 365-77.
[http://dx.doi.org/10.1007/s00266-022-03018-y] [PMID: 36097079]
[52]
Cohen JL, Scuderi N. Safety and patient satisfaction of abobotulinumtoxina for aesthetic use: A systematic review. Aesthet Surg J 2017; 37(S1): S32-44.
[http://dx.doi.org/10.1093/asj/sjx010] [PMID: 28388721]
[53]
Wu Y, Fang F, Lai W, et al. Efficacy and safety of abobotulinumtoxina for the treatment of glabellar lines in chinese patients: A pivotal, phase 3, randomized, double-blind and open-label phase study. Aesthetic Plast Surg 2023; 47(1): 351-64.
[http://dx.doi.org/10.1007/s00266-022-03164-3] [PMID: 36536093]
[54]
Dessy LA, Fallico N, Mazzocchi M, Scuderi N. Botulinum toxin for glabellar lines: A review of the efficacy and safety of currently available products. Am J Clin Dermatol 2011; 12(6): 1.
[http://dx.doi.org/10.2165/11592100-000000000-00000] [PMID: 21877763]
[55]
Coté TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005; 53(3): 407-15.
[http://dx.doi.org/10.1016/j.jaad.2005.06.011] [PMID: 16112345]
[56]
Kawashima M, Harii K, Horiuchi Y, et al. Safety, efficacy, and patient satisfaction with onabotulinumtoxina for the treatment of upper facial lines in japanese subjects. Dermatol Surg 2020; 46(4): 483-90.
[http://dx.doi.org/10.1097/DSS.0000000000002143] [PMID: 31517663]
[57]
Hexsel D, Brum C, Porto MD, et al. Full-face injections of variable total doses of abobotulinum toxin type A: A randomized, phase IV clinical trial of safety and efficacy. J Drugs Dermatol 2013; 12(12): 1356-62.
[PMID: 24301236]
[58]
Kestemont P, Hilton S, Andriopoulos B, et al. Long-term efficacy and safety of liquid abobotulinumtoxina formulation for moderate-to-severe glabellar lines: A phase III, double-blind, randomized, placebo-controlled and open-label study. Aesthet Surg J 2022; 42(3): 301-13.
[http://dx.doi.org/10.1093/asj/sjab329] [PMID: 34472596]
[59]
Chertow DS, Tan ET, Maslanka SE, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA 2006; 296(20): 2476-9.
[http://dx.doi.org/10.1001/jama.296.20.2476] [PMID: 17119144]
[60]
Gadient PM, Smith JH, Ryan SJ. Herpes zoster ophthalmicus following onabotulinumtoxinA administration for chronic migraine: A case report and literature review. Cephalalgia 2015; 35(5): 443-8.
[http://dx.doi.org/10.1177/0333102414544974] [PMID: 25135654]
[61]
Wang C, Zhao J, Gao F, Jia M, Hu L, Gao C. The efficacy and safety of intra-articular botulinum toxin type A injection for knee osteoarthritis: A meta-analysis of randomized controlled trials. Toxicon 2023; 224: 107026.
[http://dx.doi.org/10.1016/j.toxicon.2023.107026] [PMID: 36640812]
[62]
Patil A, Kassir M, Wollina U, Goldust M. Neue Botulinumtoxine in der ästhetischen Dermatologie: Ein umfassender Überblick (New botulinum toxins for aesthetic dermatology: A comprehensive review). Hautarzt 2021; 72(5): 393-402.
[http://dx.doi.org/10.1007/s00105-021-04801-9]
[63]
Corasaniti MT, Bagetta G, Nicotera P, et al. Safety of onabotulinumtoxin a in chronic migraine: A systematic review and meta-analysis of randomized clinical trials. Toxins 2023; 15(5): 332.
[http://dx.doi.org/10.3390/toxins15050332] [PMID: 37235366]
[64]
Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX-related anaphylaxis. J Forensic Sci 2005; 50: 169e72.
[66]
Setlow P. I will survive: DNA protection in bacterial spores. Trends Microbiol 2007; 15: 172e80.
[67]
Karsen H, Ceylan MR, Bayındır H, Akdeniz H. Foodborne botulism in Turkey, 1983 to 2017. Infect Dis 2019; 51(2): 91-6.
[http://dx.doi.org/10.1080/23744235.2018.1524582] [PMID: 30663916]
[68]
Bai L, Peng X, Liu Y, et al. Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT). Medicine 2018; 97(34): e10659.
[http://dx.doi.org/10.1097/MD.0000000000010659] [PMID: 30142749]
[69]
Nassif AD, Boggio RF, Espicalsky S, Faria GEL. High precision use of botulinum toxin type A (BONT-A) in aesthetics based on muscle atrophy, is muscular architecture reprogramming a possibility? A systematic review of literature on muscle atrophy after BoNT-A injections. Toxins 2022; 14(2): 81.
[http://dx.doi.org/10.3390/toxins14020081] [PMID: 35202109]
[70]
Brennan C. Update on neurotoxins for facial rejuvenation: What they are, how they work, and how to effectively and safely use them. Plast Surg Nurs 2015; 35(2): 69-75.
[http://dx.doi.org/10.1097/PSN.0000000000000091] [PMID: 26020471]
[71]
Charatan F. Germs: Biological weapons and America's secret war. BMJ 2001; 323(7321): 1135.
[72]
Miller J, Engelberg S, Broad W. Germs: Biological weapons and America's secret war. 2001; 382.
[73]
Arnon SS, Schechter R, Inglesby TV, et al. Working Group on Civilian Biodefense. Botulinum toxin as a biological weapon: Medical and public health management. JAMA 2001; 285(8): 1059-70. Erratum in JAMA 2001, 285, 2081
[http://dx.doi.org/10.1001/jama.285.8.1059] [PMID: 11209178]
[74]
Lin L, Olson ME, Eubanks LM, Janda KD. Strategies to counteract botulinum neurotoxin a: Nature’s deadliest biomolecule. Acc Chem Res 2019; 52(8): 2322-31.
[http://dx.doi.org/10.1021/acs.accounts.9b00261] [PMID: 31322847]
[75]
Ahsanuddin S, Roy S, Nasser W, Povolotskiy R, Paskhover B. Adverse events associated with botox as reported in a food and drug administration database. Aesthetic Plast Surg 2021; 45(3): 1201-9.
[http://dx.doi.org/10.1007/s00266-020-02027-z] [PMID: 33128076]
[76]
Omprakash HM, Rajendran SC. Botulinum toxin deaths: What is the fact? J Cutan Aesthet Surg 2008; 1(2): 95-7.
[http://dx.doi.org/10.4103/0974-2077.44169] [PMID: 20300354]
[77]
Tugnoli V, Eleopra R, Quatrale R, Capone JG, Sensi M, Gastaldo E. Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br J Dermatol 2002; 147(4): 808-9.
[http://dx.doi.org/10.1046/j.1365-2133.2002.49101.x] [PMID: 12366438]
[78]
Bhatia KP, Münchau A, Thompson PD, et al. Generalised muscular weakness after botulinum toxin injections for dystonia: A report of three cases. J Neurol Neurosurg Psychiatry 1999; 67(1): 90-3.
[http://dx.doi.org/10.1136/jnnp.67.1.90] [PMID: 10369829]
[79]
Wilson F. Botulinum toxin: A risks overcome by proper technique. Cosmetic Surg Times 2001; 12
[80]
Botox: Highlights of Prescribing Information. 2022. Available from: https://www.rxabbvie.com/pdf/botox_pi.pdf
[81]
Update of safety review of onabotulinumtoxinA (marketed as Botox/Botox Cosmetic), AbobotulinumtoxinA (marketed as Dysport) and RimabotulinumtoxinB (marketed as Myobloc). 2017. Available from: https://web.archive.org/web/20171115034159/https:/www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm174959.htm
[82]
Rimawi BH. Botulism in pregnancy - A clinical approach to diagnosis and management. J Matern Fetal Neonatal Med 2019; 32(18): 3125-32.
[http://dx.doi.org/10.1080/14767058.2018.1457641] [PMID: 29577785]
[83]
Brin MF, Kirby RS, Slavotinek A, et al. Pregnancy outcomes following exposure to onabotulinumtoxinA. Pharmacoepidemiol Drug Saf 2016; 25(2): 179-87.
[http://dx.doi.org/10.1002/pds.3920] [PMID: 26635276]
[84]
Newman WJ, Davis TL, Padaliya BB, et al. Botulinum toxin type A therapy during pregnancy. Mov Disord 2004; 19(11): 1384-5.
[http://dx.doi.org/10.1002/mds.20205] [PMID: 15389988]
[85]
Frevert J. Pharmaceutical, biological, and clinical properties of botulinum neurotoxin type A products. Drugs R D 2015; 15(1): 1-9.
[http://dx.doi.org/10.1007/s40268-014-0077-1] [PMID: 25559581]
[86]
Smirnoff L. Safety of OnabotulinumtoxinA in the [management of] chronic migraine in pregnancy. Front Pain Res 2022; 3: 967580.
[http://dx.doi.org/10.3389/fpain.2022.967580] [PMID: 36061414]
[87]
Altunal Ç, Şahiner İT. Relationship between psychological symptoms and self-esteem levels before and after stomach botox treatment. Med Sci Monit 2023; 29: e939618.
[http://dx.doi.org/10.12659/MSM.939618] [PMID: 37029484]
[88]
Bensen GP, Rutherford CC, Gardner TB. Systemic botulism toxicity caused by pyloric botox injection to treat gastroparesis. Case Rep Gastroenterol 2020; 14(2): 373-6.
[http://dx.doi.org/10.1159/000508854] [PMID: 32884513]
[89]
Eriksson SE, Zheng P, Morton S, et al. Predictors of favorable outcome after pyloroplasty for gastroparesis: should response to pyloric dilation or Botox injection be used as a marker of surgical outcome? Surg Endosc 2023; 37(6): 4360-9.
[http://dx.doi.org/10.1007/s00464-023-09882-2] [PMID: 36749378]
[90]
Ezaizi Y, Hasan B, Manini ML, Absah I. Intrapyloric botulinum toxin a injection for gastroparesis and functional upper gastrointestinal symptoms in children: Mayo clinic experience, review of the literature, and meta-analysis. Paediatr Drugs 2022; 24(5): 539-45.
[http://dx.doi.org/10.1007/s40272-022-00518-x] [PMID: 35768647]
[91]
Yen YA, Wang CC, Sung WW, et al. Intragastric injection of botulinum toxin A for weight loss: A systematic review and meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2022; 37(6): 983-92.
[http://dx.doi.org/10.1111/jgh.15847] [PMID: 35383416]
[92]
Cangemi DJ, Lacy BE. Gastroparesis. Curr Opin Gastroenterol 2021; 37(6): 596-601.
[http://dx.doi.org/10.1097/MOG.0000000000000782] [PMID: 34560721]
[93]
Friedenberg FK, Palit A, Parkman HP, Hanlon A, Nelson DB. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol 2008; 103(2): 416-23.
[http://dx.doi.org/10.1111/j.1572-0241.2007.01676.x] [PMID: 18070232]
[94]
Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: Management of gastroparesis. Am J Gastroenterol 2013; 108(1): 18-37.
[http://dx.doi.org/10.1038/ajg.2012.373] [PMID: 23147521]
[95]
Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: A randomized- controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther 2007; 26(9): 1251-8.
[http://dx.doi.org/10.1111/j.1365-2036.2007.03467.x] [PMID: 17944739]
[96]
Bach K, Simman R. The multispecialty toxin: A literature review of botulinum toxin. Plast Reconstr Surg Glob Open 2022; 10(4): e4228.
[http://dx.doi.org/10.1097/GOX.0000000000004228] [PMID: 35402123]
[97]
Ukleja A, Tandon K, Shah K, Alvarez A. Endoscopic botox injections in therapy of refractory gastroparesis. World J Gastrointest Endosc 2015; 7(8): 790-8.
[http://dx.doi.org/10.4253/wjge.v7.i8.790] [PMID: 26191343]
[98]
Rao AK, Sobel J, Chatham-Stephens K, Luquez C. Clinical guidelines for diagnosis and treatment of botulism, 2021. MMWR Recomm Rep 2021; 70(2): 1-30.
[http://dx.doi.org/10.15585/mmwr.rr7002a1] [PMID: 33956777]
[99]
Parrera GS, Astacio H, Tunga P, Anderson DM, Hall CL, Richardson JS. Use of botulism antitoxin heptavalent (A, B, C, D, E, F, G)-(equine) (BAT®) in clinical study subjects and patients: A 15-year systematic safety review. Toxins (Basel) 2021; 14(1): 19.
[http://dx.doi.org/10.3390/toxins14010019] [PMID: 35050996]
[100]
Shi DY, Lu JS, Mao YY, et al. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs. Appl Microbiol Biotechnol 2023; 107(10): 3205-16.
[http://dx.doi.org/10.1007/s00253-023-12515-2] [PMID: 37058230]
[101]
Anderson DM, Kumar VR, Arper DL, Kruger E, Bilir SP, Richardson JS. Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product. PLoS One 2019; 14(11): e0224700.
[http://dx.doi.org/10.1371/journal.pone.0224700] [PMID: 31697731]
[102]
Chalk CH, Benstead TJ, Pound JD, Keezer MR. Medical treatment for botulism. Cochrane Libr 2019; 4(4): CD008123.
[http://dx.doi.org/10.1002/14651858.CD008123.pub4] [PMID: 30993666]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy
Request history8.2.27PHP Version554msRequest Duration28MBMemory UsageGET article/{article_id}/{param?}Route
  • warninglog[08:41:08] LOG.warning: Optional parameter $article_id declared before required parameter $request i...
  • warninglog[08:41:09] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • warninglog[08:41:09] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[08:41:09] LOG.warning: trim(): Passing null to parameter #1 ($string) of type string is deprecated ...
  • warninglog[08:41:09] LOG.warning: Function strftime() is deprecated in /home/alphaeurekaselec/public_html/stor...
  • Booting (130ms)time
  • Application (424ms)time
  • 1 x Application (76.6%)
    424ms
    1 x Booting (23.4%)
    130ms
    14 templates were rendered
    • articlearticle.blade.php#?blade
    • includes.article_top_bannerarticle_top_banner.blade.php#?blade
    • includes.article_referencearticle_reference.blade.php#?blade
    • export_citation_formexport_citation_form.blade.php#?blade
    • includes.article_bottom_bannerarticle_bottom_banner.blade.php#?blade
    • includes.inc_related_journalsinc_related_journals.blade.php#?blade
    • includes.inc_related_ebooksinc_related_ebooks.blade.php#?blade
    • includes.journal_rightmenujournal_rightmenu.blade.php#?blade
    • includes.journal_right_bannerjournal_right_banner.blade.php#?blade
    • layouts.appapp.blade.php#?blade
    • layouts._login_access_login_access.blade.php#?blade
    • layouts._header_header.blade.php#?blade
    • layouts._main_menu_main_menu.blade.php#?blade
    • layouts._footer_menu_footer_menu.blade.php#?blade
    uri
    GET article/{article_id}/{param?}
    middleware
    web, check_user_access
    controller
    App\Http\Controllers\ArticleController@GetArticleDetails
    namespace
    App\Http\Controllers
    where
    as
    article
    file
    app/Http/Controllers/ArticleController.php:1974-2510
    36 statements were executed, 4 of which were duplicates, 32 unique. Show only duplicated329ms
    • Connection Establishedalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 9. middleware::check_user_access:24
      • 10. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 11. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address (ip_address,visitor_agent,visitor_count, created_on,updated_on) VALUES ('51359721','',1,1740472868,1740472868) ON DUPLICATE KEY UPDATE visitor_count=visitor_count + 1, updated_on=1740472868
      2.7msalphaeurekaselec_live_10_06_2022UserAccessCheck.php#24
      Backtrace
      • 11. middleware::check_user_access:24
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • INSERT INTO visitor_ip_address_detail (ip_address,visitor_url,visitor_count, created_on,updated_on) VALUES ('51359721','/article/138682',1,1740472868,1740472868)
      430μsalphaeurekaselec_live_10_06_2022UserAccessCheck.php#27
      Backtrace
      • 11. middleware::check_user_access:27
      • 12. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 14. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 15. vendor/laravel/framework/src/Illuminate/Foundation/Http/Middleware/VerifyCsrfToken.php:88
    • (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_journal_volume_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_ebook_volume_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_issue_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_article_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_trail WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_chapter_token WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) union (select `user_id`, `to_ip`, `from_ip` from (select user_id, to_ip, from_ip FROM user_access_disease_corporate WHERE to_ip >= 51359721 ORDER BY to_ip ASC LIMIT 1) as `tjv` where `from_ip` <= 51359721) limit 1
      23.68msalphaeurekaselec_live_10_06_2022UserAccess.php#784
      Bindings
      • 0: 51359721
      • 1: 51359721
      • 2: 51359721
      • 3: 51359721
      • 4: 51359721
      • 5: 51359721
      • 6: 51359721
      • 7: 51359721
      • 8: 51359721
      • 9: 51359721
      • 10: 51359721
      • 11: 51359721
      • 12: 51359721
      • 13: 51359721
      • 14: 51359721
      • 15: 51359721
      Backtrace
      • 14. app/Models/UserAccess/UserAccess.php:784
      • 15. middleware::check_user_access:114
      • 16. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Middleware/SubstituteBindings.php:50
      • 18. vendor/laravel/framework/src/Illuminate/Pipeline/Pipeline.php:183
    • SELECT at.type_name, p.copyright, p.publisher_location,m.month,y.year, a.publish_on, a.nid article_nid,a.article_id, a.pmid, a.issue_id, a.title, a.abstract,a.podcast,a.altmetric_score,a.altmetric_url,a.kudos_url, a.page_count, a.first_page, a.elocator, a.last_page, i.publication_date, a.file_name, a.file_path, a.doi, a.is_epub,a.epub_type, a.volume_id, a.is_uploaded, a.editor_choice, a.is_epub, j.image_file_name, a.article_no, a.art_type AS article_type, a.supplementary_filename,a.html_filename,a.prc_filename,a.epub_filename, a.graph_abs_lg_filename, a.graph_abs_sm_filename, a.oa_image_lg_filename, a.oa_image_sm_filename, j.journal_banner,a.animated_abstract,a.erratum_in,a.erratum_for, (CASE WHEN a.issue_id =0 THEN j.epub_price ELSE j.price END) AS sell_price, j.epub_price, j.nid AS jour_nid, j.title AS journal_title, j.issn, j.eissn,j.journal_id, j.subtitle AS jour_subtitle, v.volume_id,v.volume_name AS volume, v.year_id, i.title AS issue, i.month_id ,i.type issue_type, j.subtitle,j.formerly_title, ac.subtitle AS epub_title,a.crossmark_enabled,a.text_mining_urls,a.license_urls,a.created, a.receivedate, a.revisedate, a.acceptdate,js.js_title FROM article a LEFT JOIN article_section ac ON a.is_epub = ac.art_sec_id LEFT JOIN journal_section js ON a.js_id = js.js_id LEFT JOIN article_type at ON a.art_type = at.art_type_id LEFT JOIN issue i ON a.issue_id = i.issue_id LEFT JOIN month m ON m.id = i.month_id LEFT JOIN volume v ON v.volume_id = a.volume_id INNER JOIN year y ON y.id = v.year_id INNER JOIN journal j ON j.journal_id = a.journal_id INNER JOIN publisher p ON p.publisher_id = j.publisher_id WHERE a.article_id=138682
      1.84msalphaeurekaselec_live_10_06_2022Article.php#408
      Backtrace
      • 11. app/Models/Article.php:408
      • 12. app/Http/Controllers/ArticleController.php:2515
      • 13. app/Http/Controllers/ArticleController.php:2035
      • 14. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 15. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `journal` where `journal_id` = 29 limit 1
      900μsalphaeurekaselec_live_10_06_2022Journal.php#64
      Bindings
      • 0: 29
      Backtrace
      • 14. app/Models/Journal.php:64
      • 15. app/Http/Controllers/ArticleController.php:2516
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=29) and sj.journal_id!=29 group by `j`.`nid`) as `aggregate_table`
      1.06msalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 16. app/Models/Subject.php:200
      • 17. app/Http/Controllers/ArticleController.php:2517
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select j.nid as journal_nid,j.flyer_link,j.title ,j.issn,j.eissn,j.keyword, j.journal_id as journal_id, j.subtitle, j.image_file_name,j.description,j.journal_insight_url,j.doi from `subject_journal` as `sj` inner join `journal` as `j` on `j`.`journal_id` = `sj`.`journal_id` where j.journal_status=1 and subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=29) and sj.journal_id!=29 group by `j`.`nid` order by `j`.`journal_id` asc limit 10 offset 0
      870μsalphaeurekaselec_live_10_06_2022Subject.php#200
      Backtrace
      • 14. app/Models/Subject.php:200
      • 15. app/Http/Controllers/ArticleController.php:2517
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select count(*) as aggregate from (select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=29) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid`) as `aggregate_table`
      15.17msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 16. app/Models/Subject.php:220
      • 17. app/Http/Controllers/ArticleController.php:2518
      • 18. app/Http/Controllers/ArticleController.php:2035
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 20. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select v.nid as volume_id,e.nid,e.title,v.issn,v.eissn,v.isbn,v.eisbn,e.ebook_id, v.image_file_name,v.file_path,v.flyer_link,v.ebook_volume_id, v.volume_name,v.doi,v.year_id,v.introduction from `subject_ebook` as `se` inner join `ebook` as `e` on `e`.`ebook_id` = `se`.`ebook_id` inner join `ebook_volume` as `v` on `v`.`ebook_id` = `se`.`ebook_id` inner join `year` as `y` on `y`.`id` = `v`.`year_id` where subject_id IN (SELECT subject_id FROM subject_journal WHERE journal_id=29) and v.ebook_status='1' and y.year > 2020 group by `v`.`nid` order by `v`.`ebook_volume_id` desc limit 10 offset 0
      26.55msalphaeurekaselec_live_10_06_2022Subject.php#220
      Backtrace
      • 14. app/Models/Subject.php:220
      • 15. app/Http/Controllers/ArticleController.php:2518
      • 16. app/Http/Controllers/ArticleController.php:2035
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `keywords` where `article_id` = '138682'
      310μsalphaeurekaselec_live_10_06_2022Keywords.php#43
      Bindings
      • 0: 138682
      Backtrace
      • 13. app/Models/Keywords.php:43
      • 14. app/Http/Controllers/ArticleController.php:2519
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select * from `article_citation` where `article_id` = '138682'
      4.92msalphaeurekaselec_live_10_06_2022Article.php#1570
      Bindings
      • 0: 138682
      Backtrace
      • 13. app/Models/Article.php:1570
      • 14. app/Http/Controllers/ArticleController.php:2520
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select CONCAT_WS(' ',au.first_name, ' ', ifnull(au.initials,''), ' ', au.last_name) as authors, CONCAT(au.last_name, IFNULL(CONCAT(' ', au.initials), ''), ' ', au.first_name) AS authorsRIS, CONCAT_WS(' ',au.last_name, ' ', ifnull(au.initials,''), ' ', au.first_name) as authorsCiteAs, CONCAT_WS(' ',au.first_name, IFNULL(CONCAT(' ', au.initials), ''), IFNULL(CONCAT(' ', au.last_name), '')) as authorsmodal , `au`.*, `af`.`ror_id`, `af`.`institution`, `af`.`department`, `af`.`country`, `af`.`city`, `af`.`address`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.institution,','),''), ifnull(concat(af.department,','),''), ifnull(concat(af.address,','),''), ifnull(concat(af.city,','),''), ifnull(concat(af.country,','),''), ifnull(concat(af.postal_code,','),''), ifnull(concat(af.phone,','),''), ifnull(concat(af.fax,','),''))) SEPARATOR '|')) as `author_affiliation`, (GROUP_CONCAT(TRIM(BOTH ', ' FROM CONCAT(ifnull(concat(af.web_view,','),''))) SEPARATOR '|')) as `web_view` from `author` as `au` left join `author_affiliation` as `af` on `au`.`author_id` = `af`.`author_id` where `au`.`article_id` = '138682' group by `au`.`author_id` order by `au`.`article_id` asc, `au`.`sequence` asc
      2.01msalphaeurekaselec_live_10_06_2022Author.php#86
      Bindings
      • 0: 138682
      Backtrace
      • 13. app/Models/Author.php:86
      • 14. app/Http/Controllers/ArticleController.php:2533
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      270μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2535
      • 15. app/Http/Controllers/ArticleController.php:2035
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
    • select `subtitle` from `journal` where `continues_publication_journal` = 1
      520μsalphaeurekaselec_live_10_06_2022Article.php#1960
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/Article.php:1960
      • 14. app/Http/Controllers/ArticleController.php:2062
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • Select j.subtitle, v.volume_id as volume_id,v.year_id,y.year as year,v.volume_name, v.total_no_of_issues, i.issue_id as issue_id,i.title as issue, i.publication_date as issue_pub_date from journal j join volume v on j.journal_id = v.journal_id join issue i on v.volume_id = i.volume_id join article a on a.issue_id = i.issue_id join year y on v.year_id = y.id where j.journal_id = 29 and i.is_uploaded = 1 order by v.volume_name+0 desc, i.title+0 desc limit 1
      109msalphaeurekaselec_live_10_06_2022Issue.php#298
      Backtrace
      • 11. app/Models/Issue.php:298
      • 12. app/Http/Controllers/ArticleController.php:2068
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 1 and a.journal_id = 29 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      59.77msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2070
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select a.nid,a.publish_on, a.pmid,a.article_id,a.doi,j.journal_id,j.subtitle,v.volume_name,a.volume_id as volume_id, a.issue_id,a.title,first_page, last_page, page_count,abstract,ifnull(is_abstract,"y"),asec.title as article_section,at.type_name as article_type_name, a.article_id as ArticleID ,is_epub,epub_price,epub_type,a.created, y.year from `article` as `a` left join `article_section` as `asec` on `asec`.`art_sec_id` = `a`.`is_epub` left join `article_type` as `at` on `at`.`art_type_id` = `a`.`art_type` left join `journal` as `j` on `j`.`journal_id` = `a`.`journal_id` inner join `volume` as `v` on `a`.`volume_id` = `v`.`volume_id` inner join `year` as `y` on `v`.`year_id` = `y`.`id` where a.article_status != "W" and a.is_epub = 4 and a.journal_id = 29 and a.is_uploaded = 1 group by `a`.`article_id` order by `a`.`publish_on` desc
      58.84msalphaeurekaselec_live_10_06_2022Article.php#528
      Backtrace
      • 13. app/Models/Article.php:528
      • 14. app/Http/Controllers/ArticleController.php:2071
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select pdf, html, epub, prc from `article_metrics` where `article_id` = 138682 limit 1
      260μsalphaeurekaselec_live_10_06_2022Article.php#744
      Bindings
      • 0: 138682
      Backtrace
      • 14. app/Models/Article.php:744
      • 15. app/Http/Controllers/ArticleController.php:2091
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from content_by_diseases where content_id = 138682 and content_type = 'article' order by status desc limit 1
      290μsalphaeurekaselec_live_10_06_2022Article.php#751
      Backtrace
      • 11. app/Models/Article.php:751
      • 12. app/Http/Controllers/ArticleController.php:2094
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `node_meta` where `nid` = 227269 limit 1
      230μsalphaeurekaselec_live_10_06_2022Meta.php#30
      Bindings
      • 0: 227269
      Backtrace
      • 14. app/Models/Meta.php:30
      • 15. app/Http/Controllers/ArticleController.php:2101
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `bo`.* from `bundle_offer` as `bo` where `bo`.`bundle_status` = 'A' order by `bo`.`bundle_id` desc
      250μsalphaeurekaselec_live_10_06_2022BundleOffer.php#57
      Bindings
      • 0: A
      Backtrace
      • 13. app/Models/BundleOffer.php:57
      • 14. app/Http/Controllers/ArticleController.php:2108
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `tbl_ht_submission` as `h` where `h`.`subtitle` = 'CPD' and (h.proposal_closing_date = 0 OR TO_DAYS(FROM_UNIXTIME(h.proposal_closing_date)) >= TO_DAYS(NOW())) order by `h`.`manuscript` asc
      340μsalphaeurekaselec_live_10_06_2022Article.php#2025
      Bindings
      • 0: CPD
      Backtrace
      • 13. app/Models/Article.php:2025
      • 14. app/Http/Controllers/ArticleController.php:2112
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '138682' and content_type = 'a' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      420μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2186
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '13154' and content_type = 'i' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      320μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2207
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select count(*) as total_count, content_type_access_id as access_type from journal_access where content_type_id = '3494' and content_type = 'v' and ( (from_date <= CURDATE() and to_date >= CURDATE() and perpetual= 0) or (from_date is null and to_date is null and perpetual= 1) )
      310μsalphaeurekaselec_live_10_06_2022ContentAccess.php#647
      Backtrace
      • 11. app/Models/ContentAccess.php:647
      • 12. app/Http/Controllers/ArticleController.php:2231
      • 13. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 14. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3494) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3494) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"volume" as access_level,"" as issue_id,"" as article_id from `user_access_journal_volume_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.volume_id = 3494)
      9.88msalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2272
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 13154) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 13154) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"issue" as access_level,j.issue_id,"" as article_id from `user_access_issue_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.issue_id = 13154)
      890μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2297
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Trial Access" as access_base_text, CASE j.type WHEN 111 THEN true ELSE false END as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_trail` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 138682) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Subscribed" as access_base_text, false as terms_popup, "S" as content_download_type, null as restricted_user_access_key, null as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_corporate` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 138682) union (select j.user_access_id,j.volume_id,j.user_id,j.from_ip,j.to_ip,j.type,j.track,"Token Based Access" as access_base_text, false as terms_popup, "R" as content_download_type, j.uc_id as restricted_user_access_key, "v" as restricted_user_access_type, CASE j.track WHEN 0 THEN false ELSE true END as tracksAccessByVolume,"article" as access_level, j.issue_id, j.article_id from `user_access_article_token` as `j` inner join `user_access_info` as `info` on `j`.`user_access_id` = `info`.`user_access_id` where ((j.from_ip <= 51359721 and j.to_ip >=51359721 )) and ((j.from_date <= 1740472869 and j.to_date >= 1740472869 and j.perpetual= 0) or (j.from_date is null and j.to_date is null and j.perpetual= 1)) and j.article_id = 138682)
      840μsalphaeurekaselec_live_10_06_2022UserAccess.php#1266
      Backtrace
      • 13. app/Models/UserAccess/UserAccess.php:1266
      • 14. app/Http/Controllers/ArticleController.php:2329
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `first_page` < '578' and is_uploaded = 1 and issue_id = 13154 order by cast(first_page as SIGNED) desc limit 1
      670μsalphaeurekaselec_live_10_06_2022Article.php#1819
      Bindings
      • 0: 578
      Backtrace
      • 14. app/Models/Article.php:1819
      • 15. app/Http/Controllers/ArticleController.php:2470
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select * from `article` where `last_page` > '588' and is_uploaded = 1 and issue_id = 13154 order by cast(first_page as SIGNED) asc limit 1
      610μsalphaeurekaselec_live_10_06_2022Article.php#1831
      Bindings
      • 0: 588
      Backtrace
      • 14. app/Models/Article.php:1831
      • 15. app/Http/Controllers/ArticleController.php:2472
      • 16. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 17. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `language_id` from `multilanguage` where `short_code` = 'en'
      230μsalphaeurekaselec_live_10_06_2022ArticleController.php#2497
      Bindings
      • 0: en
      Backtrace
      • 14. app/Http/Controllers/ArticleController.php:2497
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 18. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select `source_lang_label`, `target_lang_label` from `multilanguage_labels` where `target_lang_id` = 1
      270μsalphaeurekaselec_live_10_06_2022MultiLanguage.php#23
      Bindings
      • 0: 1
      Backtrace
      • 13. app/Models/MultiLanguage.php:23
      • 14. app/Http/Controllers/ArticleController.php:2498
      • 15. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 16. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
    • select `id` from `multilanguage_article` where `article_id` = 138682 limit 1
      2.56msalphaeurekaselec_live_10_06_2022ArticleController.php#2506
      Bindings
      • 0: 138682
      Backtrace
      • 16. app/Http/Controllers/ArticleController.php:2506
      • 17. vendor/laravel/framework/src/Illuminate/Routing/Controller.php:54
      • 18. vendor/laravel/framework/src/Illuminate/Routing/ControllerDispatcher.php:43
      • 19. vendor/laravel/framework/src/Illuminate/Routing/Route.php:260
      • 20. vendor/laravel/framework/src/Illuminate/Routing/Route.php:206
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 29 and `b`.`banner_from_date` <= 1740472869 and `b`.`banner_to_date` >= 1740472869 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.15msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 29
      • 3: 1740472869
      • 4: 1740472869
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select b.banner_link, b.banner_name, b.banner_script, b.banner_remarks, b.banner_file_name, b.banner_placement, bd.content_type, bd.content_id from `tbl_banner` as `b` inner join `tbl_banner_detail` as `bd` on `bd`.`banner_id` = `b`.`banner_id` inner join `users` as `u` on `u`.`id` = `b`.`updated_by` inner join `journal` as `j` on `j`.`journal_id` = `bd`.`content_id` where `b`.`banner_journal` = 1 and `bd`.`content_type` = 'J' and `bd`.`content_id` = 29 and `b`.`banner_from_date` <= 1740472869 and `b`.`banner_to_date` >= 1740472869 and `b`.`banner_status` = 'A' order by `b`.`banner_id` desc
      1.14msalphaeurekaselec_live_10_06_2022Banner.php#95
      Bindings
      • 0: 1
      • 1: J
      • 2: 29
      • 3: 1740472869
      • 4: 1740472869
      • 5: A
      Backtrace
      • 13. app/Models/Banner.php:95
      • 14. app/Http/helpers.php:404
      • 17. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 18. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    • select count(*) as aggregate from `uc_cart_products` where cart_id='4295da4a5a7e9a094d2204a263b31df4'
      220μsalphaeurekaselec_live_10_06_2022Cart.php#271
      Backtrace
      • 15. app/Models/Cart.php:271
      • 16. view::layouts._header:260
      • 18. vendor/laravel/framework/src/Illuminate/Filesystem/Filesystem.php:124
      • 19. vendor/laravel/framework/src/Illuminate/View/Engines/PhpEngine.php:58
      • 20. vendor/laravel/framework/src/Illuminate/View/Engines/CompilerEngine.php:73
    App\Models\MultiLanguage
    1MultiLanguage.php#?
        _token
        lq9TM5atOaAzYXQj7QwwRy3MnMfiY4Isr4Ar1Ssz
        uc_cart_id
        4295da4a5a7e9a094d2204a263b31df4
        _previous
        array:1 [ "url" => "http://alpha.eurekaselect.com/article/138682" ]
        _flash
        array:2 [ "old" => [] "new" => [] ]
        PHPDEBUGBAR_STACK_DATA
        []
        path_info
        /article/138682
        status_code
        200
        
        status_text
        OK
        format
        html
        content_type
        text/html; charset=UTF-8
        request_query
        []
        
        request_request
        []
        
        request_headers
        0 of 0
        array:8 [ "accept-encoding" => array:1 [ 0 => "gzip, deflate" ] "accept" => array:1 [ 0 => "text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7" ] "user-agent" => array:1 [ 0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)" ] "upgrade-insecure-requests" => array:1 [ 0 => "1" ] "cache-control" => array:1 [ 0 => "no-cache" ] "pragma" => array:1 [ 0 => "no-cache" ] "connection" => array:1 [ 0 => "keep-alive" ] "host" => array:1 [ 0 => "alpha.eurekaselect.com" ] ]
        request_cookies
        []
        
        response_headers
        0 of 0
        array:5 [ "content-type" => array:1 [ 0 => "text/html; charset=UTF-8" ] "cache-control" => array:1 [ 0 => "no-cache, private" ] "date" => array:1 [ 0 => "Tue, 25 Feb 2025 08:41:09 GMT" ] "set-cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6InFwRHd5VEprMGVXSkRNSXUyRDdUcUE9PSIsInZhbHVlIjoiRWRCRC9GRVVzeEVpdDlpRmtKc3RnNW5BaCtmZXIwbDJMVXpjZlhoU3lMMDlIUDNSZm9aQkMwbHNLRkRxbzNMR3RIaDRoKzVCZkVRY25maXFoLzNiK2JyV21ya0orYUhGaGM2SUJlT0hzVGxaY2RTNkRscG5Mdkg4RDdZSEVvcjEiLCJtYWMiOiIyYWM0ZGViNWU3ODk3ZDg4NmFhYjg0NTc3YTk0OGJmMjYzM2IxYjIwZjhiOWU5NzlmM2Q3N2RhY2EzZmQ5MWZiIiwidGFnIjoiIn0%3D; expires=Thu, 27 Feb 2025 20:41:09 GMT; Max-Age=216000; path=/; secure; samesite=laxXSRF-TOKEN=eyJpdiI6InFwRHd5VEprMGVXSkRNSXUyRDdUcUE9PSIsInZhbHVlIjoiRWRCRC9GRVVzeEVpdDlpRmtKc3RnNW5BaCtmZXIwbDJMVXpjZlhoU3lMMDlIUDNSZm9aQkMwbHNLRkRxbzNMR3RIaDRoK" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjhGck9kcmZBM1gxeU51UCtFQ2dVNHc9PSIsInZhbHVlIjoidGFXRmlnL2NoM2ptblhFQ1Fxb2Q5eXhHNFhyNU9oWTZPVHYxKzZOdllud3EvSkpWZi9Qb1hEbWUyVGtnMEtONytyaC9CRm02UkxTR2Y3bm5wMmNVb2hxRkIrNlJWem1SeEloK0hGMmlnbkI3bk1zRkRTZlNtTnpOZWk2Vk1tWUEiLCJtYWMiOiI4NTViMDcyOGEwODJhMTUxNWY5MWRmYTViMGI0N2M0NDFiNzNkMWY3N2UzY2IxYjM0MjBkZDIzZjQ3MWRmY2RkIiwidGFnIjoiIn0%3D; path=/; secure; httponly; samesite=laxalphaeurekaselectnet_session=eyJpdiI6IjhGck9kcmZBM1gxeU51UCtFQ2dVNHc9PSIsInZhbHVlIjoidGFXRmlnL2NoM2ptblhFQ1Fxb2Q5eXhHNFhyNU9oWTZPVHYxKzZOdllud3EvSkpWZi9Qb1hEbWU" ] "Set-Cookie" => array:2 [ 0 => "XSRF-TOKEN=eyJpdiI6InFwRHd5VEprMGVXSkRNSXUyRDdUcUE9PSIsInZhbHVlIjoiRWRCRC9GRVVzeEVpdDlpRmtKc3RnNW5BaCtmZXIwbDJMVXpjZlhoU3lMMDlIUDNSZm9aQkMwbHNLRkRxbzNMR3RIaDRoKzVCZkVRY25maXFoLzNiK2JyV21ya0orYUhGaGM2SUJlT0hzVGxaY2RTNkRscG5Mdkg4RDdZSEVvcjEiLCJtYWMiOiIyYWM0ZGViNWU3ODk3ZDg4NmFhYjg0NTc3YTk0OGJmMjYzM2IxYjIwZjhiOWU5NzlmM2Q3N2RhY2EzZmQ5MWZiIiwidGFnIjoiIn0%3D; expires=Thu, 27-Feb-2025 20:41:09 GMT; path=/; secureXSRF-TOKEN=eyJpdiI6InFwRHd5VEprMGVXSkRNSXUyRDdUcUE9PSIsInZhbHVlIjoiRWRCRC9GRVVzeEVpdDlpRmtKc3RnNW5BaCtmZXIwbDJMVXpjZlhoU3lMMDlIUDNSZm9aQkMwbHNLRkRxbzNMR3RIaDRoK" 1 => "alphaeurekaselectnet_session=eyJpdiI6IjhGck9kcmZBM1gxeU51UCtFQ2dVNHc9PSIsInZhbHVlIjoidGFXRmlnL2NoM2ptblhFQ1Fxb2Q5eXhHNFhyNU9oWTZPVHYxKzZOdllud3EvSkpWZi9Qb1hEbWUyVGtnMEtONytyaC9CRm02UkxTR2Y3bm5wMmNVb2hxRkIrNlJWem1SeEloK0hGMmlnbkI3bk1zRkRTZlNtTnpOZWk2Vk1tWUEiLCJtYWMiOiI4NTViMDcyOGEwODJhMTUxNWY5MWRmYTViMGI0N2M0NDFiNzNkMWY3N2UzY2IxYjM0MjBkZDIzZjQ3MWRmY2RkIiwidGFnIjoiIn0%3D; path=/; secure; httponlyalphaeurekaselectnet_session=eyJpdiI6IjhGck9kcmZBM1gxeU51UCtFQ2dVNHc9PSIsInZhbHVlIjoidGFXRmlnL2NoM2ptblhFQ1Fxb2Q5eXhHNFhyNU9oWTZPVHYxKzZOdllud3EvSkpWZi9Qb1hEbWU" ] ]
        session_attributes
        0 of 0
        array:5 [ "_token" => "lq9TM5atOaAzYXQj7QwwRy3MnMfiY4Isr4Ar1Ssz" "uc_cart_id" => "4295da4a5a7e9a094d2204a263b31df4" "_previous" => array:1 [ "url" => "http://alpha.eurekaselect.com/article/138682" ] "_flash" => array:2 [ "old" => [] "new" => [] ] "PHPDEBUGBAR_STACK_DATA" => [] ]
        ClearShow all
        Date ↕MethodURLData
        #12025-02-25 08:41:09GET/article/138682514361